# PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding

> **NCT02557672** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 106 (actual)

## Conditions studied

- Bleeding
- Blood Loss, Surgical
- Cardiovascular Surgical Procedures
- Prothrombin Complex Concentrates
- Fresh Frozen Plasma

## Interventions

- **DRUG:** Prothrombin complex concentrate (Human)
- **BIOLOGICAL:** Fresh frozen plasma (FFP)

## Key facts

- **NCT ID:** NCT02557672
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2021-06
- **Final completion:** 2022-01
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2022-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02557672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02557672, "PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02557672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*